aceRNA Technologies Co., Ltd.
PrivateLast Round
Series B
May 7, 2024
Total Funding Raised
$14.05M
Company Overview
aceRNA Technologies Co., Ltd. is a biotechnology company that develops mRNA-based and gene therapies using proprietary RNA Switch technology for cell-specific therapeutic expression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aceRNA Technologies Co., Ltd. Comparables
Compare aceRNA Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radar Therapeutics | 84% | |
| Combined Therapeutics | 83% | |
| Rgenta Therapeutics | 80% | |
aceRNA Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 7, 2024 | ||||
| Series B | Dec 20, 2021 | ||||
| Series A | Oct 31, 2019 | ||||
| Seed | Nov 8, 2018 |
aceRNA Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCI Partners Co., Ltd. | Series B |
| Mitsubishi UFJ Capital | Series B |
| Kyoto University Innovation Capital | Seed, Series A |
| SMBC Venture Capital | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 100% MoM, reaching 2.4K.
- Jan 24, 2025
Monthly visitors grew 34% MoM, from 605 to 808.
aceRNA Technologies Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about aceRNA Technologies Co., Ltd.'s valuation, stock price, and market status.